RE:THC BIOMEDIf you are looking for a growth play I think C.BE is worth a look. They have real assets in play, more than THC. Although, they are currently in a similar situation as APHA. Something about unfair business practices. Investor presentation has them ranked 5th among licensed producers with funded production and ranked the lowest in terms of market cap. And they just did a 7-1 forward split for apparently trying to make shorts cover their positions. The share price is trading at .105c